Open Access
Volume 18, Number 1, Janvier-Février 2011
Dossier : Lipides et inflammation
Page(s) 34 - 38
Section Nutrition – Santé
Published online 15 January 2011
  • Argiles JM, Anker SD, Evans WJ, et al. Consensus on cachexia definitions. J Am Med Dir Assoc 2010 ; 11 : 229–230. [CrossRef] [PubMed] [Google Scholar]
  • Baracos VE. Regulation of skeletal-muscle-protein turnover in cancer-associated cachexia. Nutrition 2000 ; 16 : 1015–1018. [CrossRef] [PubMed] [Google Scholar]
  • Bougnoux P, Hajjaji N, Ferrasson MN, Giraudeau B, Couet C, Le Floch O. Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial. Br J Cancer 2009 ; 101 : 1978–1985. [CrossRef] [PubMed] [Google Scholar]
  • Busquets S, Aranda X, Ribas-Carbo M, Azcon-Bieto J, Lopez-Soriano FJ, Argiles JM. Tumour necrosis factor-alpha uncouples respiration in isolated rat mitochondria. Cytokine 2003 ; 22 : 1–4. [CrossRef] [PubMed] [Google Scholar]
  • Calder PC. Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale. Biochimie 2009 ; 91 : 791–795. [CrossRef] [PubMed] [Google Scholar]
  • Colomer R, Moreno-Nogueira JM, Garcia-Luna PP, et al. N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr 2007 ; 97 : 823–831. [CrossRef] [PubMed] [Google Scholar]
  • Costelli P, Bossola M, Muscaritoli M, et al. Anticytokine treatment prevents the increase in the activity of ATP-ubiquitin- and Ca(2+)-dependent proteolytic systems in the muscle of tumour-bearing rats. cytokine 2002 ; 19 : 1–5. [CrossRef] [PubMed] [Google Scholar]
  • Costelli P, Muscaritoli M, Bonetto A, et al. Muscle myostatin signalling is enhanced in experimental cancer cachexia. Eur J Clin Invest 2008 ; 38 : 531–538. [CrossRef] [PubMed] [Google Scholar]
  • Dewey A, Dean T, Higgins B, Johnson I. Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane Database Syst Rev 2007 : CD004597. [Google Scholar]
  • Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980 ; 69 : 491–497. [CrossRef] [PubMed] [Google Scholar]
  • Dumas JF, Goupille C, Julienne CM, et al. Efficiency of oxidative phosphorylation in liver mitochondria is decreased in a rat model of peritoneal carcinosis. J Hepatol 2011 ; 54 : 320–327. [CrossRef] [PubMed] [Google Scholar]
  • Dumas JF, Goupille C, Pinault M, et al. n-3 PUFA-enriched diet delays the occurrence of cancer cachexia in rat with peritoneal carcinosis. Nutr Cancer 2010 ; 62 : 343–350. [CrossRef] [PubMed] [Google Scholar]
  • Hellerstein MK, Meydani SN, Meydani M, Wu K, Dinarello CA. Interleukin-1-induced anorexia in the rat. Influence of prostaglandins. J Clin Invest 1989 ; 84 : 228–235. [CrossRef] [PubMed] [Google Scholar]
  • Jho DH, Babcock TA, Tevar R, Helton WS, Espat NJ. Eicosapentaenoic acid supplementation reduces tumor volume and attenuates cachexia in a rat model of progressive non-metastasizing malignancy. JPEN J Parenter Enteral Nutr 2002 ; 26 : 291–297. [CrossRef] [PubMed] [Google Scholar]
  • Lai V, George J, Richey L, et al. Results of a pilot study of the effects of celecoxib on cancer cachexia in patients with cancer of the head, neck, and gastrointestinal tract. Head Neck 2008 ; 30 : 67–74. [CrossRef] [PubMed] [Google Scholar]
  • Langstein HN, Doherty GM, Fraker DL, Buresh CM, Norton JA. The roles of gamma-interferon and tumor necrosis factor alpha in an experimental rat model of cancer cachexia. Cancer Res 1991 ; 51 : 2302–2306. [PubMed] [Google Scholar]
  • Llovera M, Carbo N, Lopez-Soriano J, et al. Different cytokines modulate ubiquitin gene expression in rat skeletal muscle. Cancer Lett 1998 ; 133 : 83–87. [CrossRef] [PubMed] [Google Scholar]
  • Lopez-Soriano J, Llovera M, Carbo N, Garcia-Martinez C, Lopez-Soriano FJ, Argiles JM. Lipid metabolism in tumour-bearing mice: studies with knockout mice for tumour necrosis factor receptor 1 protein. Mol Cell Endocrinol 1997 ; 132 : 93–99. [CrossRef] [PubMed] [Google Scholar]
  • Lundholm K, Gelin J, Hyltander A, et al. Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res 1994 ; 54 : 5602–5606. [PubMed] [Google Scholar]
  • Lundholm K, Daneryd P, Korner U, Hyltander A, Bosaeus I. Evidence that long-term COX-treatment improves energy homeostasis and body composition in cancer patients with progressive cachexia. Int J Oncol 2004 ; 24 : 505–512. [PubMed] [Google Scholar]
  • Mantovani G, Maccio A, Madeddu C, et al. Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia. J Mol Med 2010 ; 88 : 85–92. [CrossRef] [PubMed] [Google Scholar]
  • Morley JE, Thomas DR, Wilson MM. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 2006 ; 83 : 735–743. [CrossRef] [PubMed] [Google Scholar]
  • Muscaritoli M, Anker SD, Argiles J. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 2010 ; 29 : 154–159. [CrossRef] [PubMed] [Google Scholar]
  • Ng EH, Lowry SF. Nutritional support and cancer cachexia. Evolving concepts of mechanisms and adjunctive therapies. Hematol Oncol Clin North Am 1991 ; 5 : 161–184. [PubMed] [Google Scholar]
  • Perumal SS, Shanthi P, Sachdanandam P. Energy-modulating vitamins – a new combinatorial therapy prevents cancer cachexia in rat mammary carcinoma. Br J Nutr 2005 ; 93 : 901–909. [CrossRef] [PubMed] [Google Scholar]
  • Pfitzenmaier J, Vessella R, Higano CS, Noteboom JL, Wallace D Jr., Corey E. Elevation of cytokine levels in cachectic patients with prostate carcinoma. Cancer 2003 ; 97 : 1211–1216. [CrossRef] [PubMed] [Google Scholar]
  • Ramos EJ, Middleton FA, Laviano A, et al. Effects of omega-3 fatty acid supplementation on tumor-bearing rats. J Am Coll Surg 2004 ; 199 : 716–723. [CrossRef] [PubMed] [Google Scholar]
  • Rolfe DF, Brown GC. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev 1997 ; 77 : 731–758. [PubMed] [Google Scholar]
  • Samavati L, Lee I, Mathes I, Lottspeich F, Huttemann M. Tumor necrosis factor alpha inhibits oxidative phosphorylation through tyrosine phosphorylation at subunit I of cytochrome c oxidase. J Biol Chem 2008 ; 283 : 21134–21144. [CrossRef] [PubMed] [Google Scholar]
  • Scott HR, McMillan DC, Forrest LM, Brown DJ, McArdle CS, Milroy R. The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer 2002 ; 87 : 264–267. [CrossRef] [PubMed] [Google Scholar]
  • Soda K, Kawakami M, Kashii A, Miyata M. Characterization of mice bearing subclones of colon 26 adenocarcinoma disqualifies interleukin-6 as the sole inducer of cachexia. Jpn J Cancer Res 1994 ; 85 : 1124–1130. [CrossRef] [PubMed] [Google Scholar]
  • Strassmann G, Fong M, Kenney JS, Jacob CO. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 1992 ; 89 : 1681–1684. [CrossRef] [PubMed] [Google Scholar]
  • Tatsumi T, Matoba S, Kawahara A, et al. Cytokine-induced nitric oxide production inhibits mitochondrial energy production and impairs contractile function in rat cardiac myocytes. J Am Coll Cardiol 2000 ; 35 : 1338–1346. [CrossRef] [PubMed] [Google Scholar]
  • Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev 2009 ; 89 : 381–410. [CrossRef] [PubMed] [Google Scholar]
  • Togni V, Ota CC, Folador A, et al. Cancer cachexia and tumor growth reduction in Walker 256 tumor-bearing rats supplemented with N-3 polyunsaturated fatty acids for one generation. Nutr Cancer 2003 ; 46 : 52–58. [CrossRef] [PubMed] [Google Scholar]
  • Whitehouse AS, Smith HJ, Drake JL, Tisdale MJ. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid. Cancer Res 2001 ; 61 : 3604–3609. [PubMed] [Google Scholar]
  • Wigmore SJ, Ross JA, Falconer JS, et al. The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition 1996 ; 12 : S27–S30. [PubMed] [Google Scholar]
  • Wigmore SJ, Fearon KC, Maingay JP, Ross JA. Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. Clin Sci (Lond) 1997 ; 92 : 215–221. [PubMed] [Google Scholar]
  • Zhang HH, Halbleib M, Ahmad F, Manganiello VC, Greenberg AS. Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes 2002 ; 51 : 2929–2935. [CrossRef] [PubMed] [Google Scholar]
  • Zhou X, Wang JL, Lu J, et al. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 2010 ; 142 : 531–543. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.